C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
11/2006
11/28/2006	CA2305580C Process for production of substituted alkylamine or its salt
11/28/2006	CA2275379C Use of pramipexole in the treatment of restless legs syndrome
11/23/2006	WO2006125208A1 Inhibitors of matrix metalloproteinases
11/23/2006	WO2006124887A1 Iminothiazolidinone derivatives as sfrp-1 antagonists
11/23/2006	WO2006123088A2 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides
11/23/2006	WO2006122949A1 Malononitriles and their use as pesticides
11/23/2006	WO2006122933A1 Thiazole carboxylic acid anilides
11/23/2006	WO2006122546A1 Non-peptidic inhibitors of akap/pka interaction
11/23/2006	WO2006110173A3 Novel compounds
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	US20060264481 Therapeutic modulation of PPARgamma activity
11/23/2006	US20060264435 Novel compounds
11/23/2006	DE102005024012A1 Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln Use of 2,5-disubstituted thiazol-4-one derivatives in medicaments
11/23/2006	CA2611896A1 Non-peptidic inhibitors of akap/pka interaction
11/23/2006	CA2609002A1 Use of 2,5-disubstituted thiazol-4-one derivatives in the production of drugs for the treatment of disorders or diseases which are mediated at least partly by vanilloid receptors 1(vr1/trpv1 receptors)
11/23/2006	CA2608424A1 Thiazole carboxylic acid anilides
11/23/2006	CA2608240A1 Multicyclic compounds and methods of their use
11/23/2006	CA2607422A1 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1723132A1 Ep2 receptor agonists
11/22/2006	EP1723129A1 1-akan-2-ol substituted piperazine and piperidine compounds
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	EP1723127A2 Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
11/22/2006	EP1723102A2 N-substituted benzene sulfonamides
11/22/2006	EP1722791A2 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/22/2006	EP1722789A2 Therapeutic modulation of ppar (gamma) activity
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1277752B1 Process for producing optically active sulfoxide derivative
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1865251A Leucogen diastereoisomeride structural confirmation and determination method
11/22/2006	CN1285597C 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
11/22/2006	CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution
11/21/2006	US7138483 Monomers, conjugated polymers and electronic devices using such polymers
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2272285C Amide derivatives and medicinal compositions thereof
11/21/2006	CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006	WO2006121223A1 Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006120268A1 Method for the resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol and intermediate compounds
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060258722 Condensed ring compound
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060257987 Ppar modulators
11/16/2006	US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/16/2006	DE102005022182A1 Modulatoren der PDZ-Domäne Modulators of the PDZ domain
11/16/2006	DE102005021367A1 New thiazolecarboxylic acid anilide compounds useful for combating harmful fungus, particularly Botrytis
11/16/2006	CA2607988A1 Method for the resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol and intermediate compounds
11/16/2006	CA2607617A1 Thiazole compounds and methods of use
11/15/2006	EP1721905A1 Thiazole derivative
11/15/2006	EP1721902A1 Production methods of thiazoline compounds and optically active alpha-alkylcysteine
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720845A1 Isothiourea derivatives
11/15/2006	EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP1142885B1 2-(n-cyanoimino)thiazolidin-4-one derivatives
11/15/2006	EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006	CN1863783A Compounds having thrombopoietin receptor agonism
11/15/2006	CN1863766A Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient
11/15/2006	CN1284777C 5-membered heterocycles, preparation and use thereof as medicine
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006118268A1 Therapeutic agent for chronic obstructive pulmonary disease
11/09/2006	WO2006117743A1 Substituted aromatic compounds as antidiabetic agents
11/09/2006	WO2006117669A1 Amide resorcinol compounds
11/09/2006	WO2006117614A1 Process for the preparation of pramipexole and new anhydrous forms of its dihydrochloride
11/09/2006	WO2006041921A3 Preparation and uses of rhodanine derivatives
11/09/2006	WO2006020767A3 Thiazole based inhibitors of atp-utilizing enzymes
11/09/2006	US20060252803 Hydrogenation of precursors to thiazolidinedione antihyperglycemics
11/09/2006	US20060252800 Anti-leishmania agent
11/09/2006	US20060252760 Farnesyl transferase inhibitors
11/09/2006	CA2605985A1 Amide resorcinol compounds
11/09/2006	CA2603060A1 Therapeutic agent for chronic obstructive pulmonary disease
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1719126A1 Optical recording materials having high storage density
11/08/2006	EP1718667A2 Heterocyclic self-immolative linkers and conjugates
11/08/2006	EP1718646A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
11/08/2006	EP1718625A1 Compounds
11/08/2006	EP1718624A1 Benzamide derivatives and their use as glucokinase activating agents
11/08/2006	EP1718342A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/08/2006	EP1718297A2 Novel chemical compounds
11/08/2006	EP1294691B1 Serine protease inhibitors

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 337